4
Changes in Ownership
TriSalus Life Sciences, Inc. Filed Acc 0001415889-25-003621
Options or other derivatives
- Director acquired 44,750 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Wahlstrom Mats Director | 2025-02-10 | Other acquisition · Series A Convertible Preferred Stock | +44,750 | 94,750 | I | ||
Loading xslF345X05/form4-02112025_100210.xml…